Literature DB >> 23202627

[Clinical significance of saliva urea, creatinine, and uric acid levels in patients with chronic kidney disease].

Yuncheng Xia1, Canhui Peng, Zhifang Zhou, Ping Cheng, Lin Sun, Youming Peng, Ping Xiao.   

Abstract

OBJECTIVE: To explore the changes and clinical significance of saliva urea, creatinine (Cr), uric acid (UA) in both healthy people and chronic kidney disease (CKD) patients, and to provide a noninvasive, quick, accurate and reliable test to diagnose kindey disease.
METHODS: Urea, Cr and UA in the saliva and serum collected from both healthy people and the CKD patients were measured by biochemical analyzer. We calculated the correlation coefficient of Urea, Cr and UA between the saliva and serum, compared the levels of saliva Urea, Cr and UA among CKD patients in different periods, drew the receiver operation characteristic (ROC) curve and analyzed the sensitivity and specificity of saliva Urea, Cr and UA to predict CKD patients in various periods.
RESULTS: The concentrations of Urea, Cr and UA in both the saliva and the serum were positively correlated in healthy individuals and CKD patients (r = 0.918, 0.932, 0.840 and 0.984, 0.971, 0.920). The levels of saliva Urea, Cr and UA in the CKD patients were significantly higher than those of healthy people (P<0.05). Saliva Urea, Cr and UA concentrations of middle and late stage CKD patients were obviously higher than those of healthy people and early stage CKD patients (P<0.05). Areas under the curve (AUC) of the ROC of Urea, Cr and UA to diagnose diverse periods of CKD were 0.898, 0.897 and 0.848. The sensitivity was 0.806, 0.776 and 0.704; and the specificity was 0.968, 0.989 and 0.871.
CONCLUSION: The levels of Urea, Cr and UA between the saliva and the serum are closely related. The concentration of saliva Urea, Cr and UA can reflect the renal damage, monitor kidney function of the CKD patients, and help diagnose middle to late stage CKD patients. It is a simple, nonivasive and quick method.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23202627     DOI: 10.3969/j.issn.1672-7347.2012.11.016

Source DB:  PubMed          Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-7347


  7 in total

1.  The validity, stability, and utility of measuring uric acid in saliva.

Authors:  Jenna L Riis; Crystal I Bryce; Marla J Matin; John L Stebbins; Olga Kornienko; Lauren van Huisstede; Douglas A Granger
Journal:  Biomark Med       Date:  2018-06-06       Impact factor: 2.851

2.  Determination of salivary urea and uric acid of patients with halitosis.

Authors:  Faezeh Khozeimeh; Nakisa Torabinia; Shirin Shahnaseri; Hooman Shafaee; Seyed Amir Mousavi
Journal:  Dent Res J (Isfahan)       Date:  2017 Jul-Aug

3.  Diagnostic accuracy of salivary creatinine, urea, and potassium levels to assess dialysis need in renal failure patients.

Authors:  Bhavana S Bagalad; K P Mohankumar; G S Madhushankari; Mandana Donoghue; Puneeth Horatti Kuberappa
Journal:  Dent Res J (Isfahan)       Date:  2017 Jan-Feb

4.  Can salivary creatinine and urea levels be used to diagnose chronic kidney disease in children as accurately as serum creatinine and urea levels? A case-control study.

Authors:  Rahime Renda
Journal:  Ren Fail       Date:  2017-11       Impact factor: 2.606

5.  Salivary creatinine estimation as an alternative to serum creatinine in chronic kidney disease patients.

Authors:  Ramesh Venkatapathy; Vasupradha Govindarajan; Nirima Oza; Sreejith Parameswaran; Balamurali Pennagaram Dhanasekaran; Karthikshree V Prashad
Journal:  Int J Nephrol       Date:  2014-04-10

6.  Comparison of Widely Used Biochemical Analytes in the Serum and Saliva Samples of Dialysis Patients.

Authors:  Medine Alpdemir; Mehmet Eryilmaz; Mehmet Fatih Alpdemir; Güler Topçu; Alper Azak; Doğan Yücel
Journal:  J Med Biochem       Date:  2018-07-01       Impact factor: 3.402

7.  Salivary creatinine as a diagnostic tool for evaluating patients with chronic kidney disease.

Authors:  Dada Oluwaseyi Temilola; Karla Bezuidenhout; Rajiv Timothy Erasmus; Lawrence Stephen; Mogamat Razeen Davids; Haly Holmes
Journal:  BMC Nephrol       Date:  2019-10-29       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.